References
- Lieberman JA, Stroup TS, McEvoy JP et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–23
- Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003;29:15–31
- Straus SE. Individualizing treatment decisions. The likelihood of being helped or harmed. Eval Health Prof 2002;25:210–24
- Muir Gray JA. Evidence-Based Healthcare: How to Make Heath Policy and Management Decisions. London: Churchill Livingstone, 1997
- Gray GE, Pinson LA. Evidence-based medicine and psychiatric practice. Psychiatr Q 2003;74:387–99
- Pinson L, Gray GE. Psychopharmacology: number needed to treat: an underused measure of treatment effect. Psychiatr Serv 2003;54: 145–6, 154
- Citrome L, Stroup TS. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians? Int J Clin Pract 2006;60:933–40
- Gray GE. Concise Guide to Evidence Based Psychiatry. Arlington, VA: American Psychiatric Publishing Inc., 2004
- DiCenso A. Clinically useful measures of the effects of treatment. Evid Based Nurs 2001;4:36–9
- Lorenz WF. Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry 1922;8:184–96